文献速递中医内科中药与中成药合理使用

脉络舒通丸治疗精索静脉曲张相关男性不育的植物化学特征与多靶点机制

Mailuoshutong pill for varicocele-associated male infertility-Phytochemical characterisation and multitarget mechanism.
PubMed 文献 · Front Pharmacol · 2022-09-09

本研究采用UHPLC-MS/MS分析脉络舒通丸成分,通过网络药理学构建「药物-成分-靶点-疾病」网络,并结合药理实验验证其对精索静脉曲张相关男性不育的作用机制。结果显示,该药可能通过抑制PI3K/Akt/mTOR通路激活、降低HIF1α表达,减轻睾丸氧化应激与凋亡,改善精索静脉曲张所致睾丸萎缩与生精损伤。

要点

  • 脉络舒通丸可能通过多成分、多靶点改善精索静脉曲张相关男性不育。
  • 药理实验显示其可减轻睾丸氧化应激、凋亡及生精细胞损伤。
  • 机制可能与抑制PI3K/Akt/mTOR通路及降低HIF1α表达有关。

核心结论

  • 脉络舒通丸可抑制PI3K/Akt/mTOR信号通路激活并降低HIF1α表达,减轻精索静脉曲张诱导的睾丸氧化应激与凋亡。

研究设计与样本

  • 研究采用UHPLC-MS/MS测定脉络舒通丸成分,通过网络分析构建「药物-成分-靶点-疾病」网络并预测生物学功能与信号通路,最后通过药理实验验证疗效与潜在机制。

主要发现

  • 网络分析显示芹菜素、柠檬苦素、山奈酚、鄂西香茶菜酸等62种成分可能是脉络舒通丸治疗精索静脉曲张相关男性不育的主要活性成分。
  • VEGFA、PIK3CA、AKT1、MTOR等28个靶点被认为是核心靶点,HIF-1、雌激素、PI3K/Akt、mTOR等信号通路可能是关键通路。
  • 药理实验发现脉络舒通丸改善精索静脉曲张诱导的睾丸萎缩,减轻对精原细胞和生精小管的损伤。
  • 脉络舒通丸降低ROS和MDA水平,升高抗氧化酶(GSH、GSH-Px、SOD、CAT)水平。
  • TUNEL染色和免疫荧光显示脉络舒通丸减少睾丸组织凋亡,降低BAX并升高BCL2;Western blot显示其降低PI3K、AKT、mTOR蛋白磷酸化及HIF1α表达。

临床怎么用

  • 对于精索静脉曲张相关男性不育,脉络舒通丸可能作为改善睾丸氧化应激与凋亡的潜在治疗选择,但需结合临床辨证与现有证据综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Varicocele (VC) is a relatively common and treatable cause of male infertility. Mailuoshutong pill (MLST), a traditional Chinese patent medicine, is widely used for treating varicose vein disease, but the underlying mechanism of MLST on varicocele-associated male infertility is unclear. Objective: To reveal the phytochemical characterisation and multitarget mechanism of MLST on varicocele-associated male infertility. Methods: The components in MLST were determined using UHPLC-MS/MS. Through network analysis, we constructed the "Drug-Components-Targets-Disease" network and predicted the potential biological functions and signaling pathways of MLST. Finally, the therapeutic effects and potential mechanisms of MLST were discovered by pharmacological experiments. Results: By network analysis, the "Drug-Components-Targets-Disease" network was constructed, 62 components such as apigenin, limonin, kaempferol, and obacunoic acid may be the main active components of MLST for varicocele-associated male infertility, 28 targets such as VEGFA, PIK3CA, AKT1, and MTOR are considered as hub targets, signaling pathways such as HIF-1, Estrogen, PI3K/Akt, and mTOR may be key pathways for MLST against varicocele-associated male infertility. Through pharmacological experiments, we found that MLST ameliorated VC-induced testicular atrophy. Further histomorphology showed that MLST reduced VC-induced damage to testicular spermatogonia and seminiferous tubule, while MLST reduced ROS and MDA levels and increased antioxidant enzymes (GSH, GSH-Px, SOD, and CAT) levels. TUNEL staining and immunofluorescence showed that MLST reduced VC-induced apoptosis in testicular tissue, decreased BAX, and increased BCL2. Western blot results showed that MLST decreased the phosphorylation of PI3K, AKT, and mTOR proteins, and decreased the expression of HIF1α. Conclusion: The phytochemical characterisation and multitarget mechanism of MLST on varicocele-associated male infertility were discovered using network analysis and pharmacological experiments. We verified that MLST can inhibit the activation of the PI3K/Akt/mTOR signaling pathway, reduce the expression of HIF1α, and further attenuate VC-induced oxidative stress and apoptosis in the testis. These findings provide evidence for the therapeutic role of MLST in varicocele-associated male infertility.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Lv D, Ji Y, Zhang Q, et al. Mailuoshutong pill for varicocele-associated male infertility-Phytochemical characterisation and multitarget mechanism. Front Pharmacol. 2022. PMID: 36160417. doi:10.3389/fphar.2022.961011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。